Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · IEX Real-Time Price · USD
1.195
+0.075 (6.70%)
At close: Jul 2, 2024, 4:00 PM
1.218
+0.023 (1.92%)
After-hours: Jul 2, 2024, 7:28 PM EDT
Gain Therapeutics Revenue
In the year 2023, Gain Therapeutics had annual revenue of $55.18K, a decrease of -60.62%.
Revenue (ttm)
$55.18K
Revenue Growth
-60.62%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
21.57M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 55.18K | -84.93K | -60.62% |
Dec 31, 2022 | 140.11K | -24.89K | -15.08% |
Dec 31, 2021 | 164.99K | 136.11K | 471.29% |
Dec 31, 2020 | 28.88K | -12.42K | -30.07% |
Dec 31, 2019 | 41.30K | 20.69K | 100.40% |
Dec 31, 2018 | 20.61K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ATI Physical Therapy | 713.56M |
Cumberland Pharmaceuticals | 38.83M |
American Shared Hospital Services | 21.62M |
TRxADE HEALTH | 6.66M |
Akso Health Group | 2.20M |
Oncternal Therapeutics | 1.15M |
GANX News
- 4 days ago - Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024 - GlobeNewsWire
- 5 days ago - Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO - GlobeNewsWire
- 5 days ago - Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson's disease - GlobeNewsWire
- 7 days ago - Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 19 days ago - Gain Therapeutics Announces Pricing of $11.0 Million Public Offering - GlobeNewsWire
- 19 days ago - Gain Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 4 weeks ago - Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024 - GlobeNewsWire
- 7 weeks ago - Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update - GlobeNewsWire